practolol has been researched along with sphingosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amin, S; Plano, D; Sharma, AK | 1 |
Endo, H; Hanzawa, A; Kanegae, H; Matsumoto, K; Miyazawa, K; Nakabayashi, Y; Shinoda, H; Suda, Y; Suetsugu, M; Takano, A; Takeshita, A; Tanaka, S; Ueyama, Y; Yasui, T | 1 |
1 review(s) available for practolol and sphingosine
Article | Year |
---|---|
Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
Topics: Clofibrate; Drug Combinations; Enzyme Inhibitors; Humans; Isoenzymes; Lysophospholipids; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Practolol; Sphingosine | 2014 |
1 other study(ies) available for practolol and sphingosine
Article | Year |
---|---|
Sphingosine 1-phosphate acts as a signal molecule in ceramide signal transduction of TNF-alpha-induced activator protein-1 in osteoblastic cell line MC3T3-E1 cells.
Topics: 3T3 Cells; Animals; Blotting, Northern; Ceramides; Chemokine CCL2; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Gene Expression; Genes, fos; Genes, jun; Lysophospholipids; Mice; Mice, Inbred C57BL; Morpholines; Osteoblasts; Propanolamines; Pyrrolidines; Recombinant Proteins; Second Messenger Systems; Sphingomyelin Phosphodiesterase; Sphingosine; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2005 |